Business / Finance

RSS

ABA honors Acorda Therapeutics president with 2011 Stevie Award

Acorda Therapeutics, Inc. announced that Ron Cohen, M.D., President and CEO of Acorda Therapeutics, was awarded the 2011 Stevie Award for Executive of the Year in the Health Products & Services category at the 9th Annual American Business Awards (ABA) ceremony held on June 20, 2011.

24 Jun 2011

Youngevity announces acquisition of R-Garden

Youngevity Essential Life Sciences, an international nutritional products company, announced its acquisition of R-Garden, Inc. The acquisition of R-Garden's Customers, Distributors, and Product Line expands Youngevity's already substantial "network cloud" of Distributors and Customers and their social networking reach.

24 Jun 2011

Clinical trial management systems market to reach over $1.76B by 2017

It is expected that the clinical trial management systems (CTMS) market will achieve a value of $1.76 billion by 2017, according to a new report on companiesandmarkets.com.

24 Jun 2011

Electrophysiology mapping and ablation devices market to reach over $2.1B by 2017

By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.

24 Jun 2011

BioMarin to acquire Pfizer's Ireland manufacturing plant

BioMarin Pharmaceutical Inc. announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland.

24 Jun 2011

Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits

Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company.

23 Jun 2011

Cyanotech fourth quarter revenues increase to $5,218,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

23 Jun 2011

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Fero Industries, Inc. is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.

23 Jun 2011

Rite Aid reports net loss of $63.1 million for first quarter ended May 28, 2011

Rite Aid Corporation today reported financial results for the first quarter ended May 28, 2011.

23 Jun 2011

Biosign grants 3,115,000 stock options at $0.92 per share

Biosign Technologies Inc. announced today the grant of an aggregate of 3,115,000 stock options pursuant to the Company's stock option plan. An aggregate of 1,115,000 of such options were granted effective June 16, 2011 to four directors of the Company.

23 Jun 2011

Insight into future development of global pharmaceutical industry

Alacrita, which is changing the face of life science consulting, has published an insight into the future development of the global pharmaceutical industry.

23 Jun 2011

AP: Walgreens, Express Scripts at odds in contract negotiations

The Walgreen Company said on Tuesday that it was willing to walk away from more than $5 billion in annual revenue because the pharmacy benefits manager Express Scripts did not pay it enough to fill prescriptions.

23 Jun 2011

Sanofi Pasteur establishes new vaccine research and development facility in Canada

Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.

23 Jun 2011

US Clinical Laboratories acquires VLS

US Clinical Laboratories today acquired Vidalia Lab Services (VLS), headquartered in Vidalia, Georgia. This marks the Company's first market entry outside the greater Houston area.

23 Jun 2011

Elavon wins Merchant Acquirer of the Year Award at Cards & Payments European Conference

At a glittering award ceremony at the Westin Grand in Frankfurt last night, Elavon, a leading global payments provider and wholly-owned subsidiary of U.S. Bancorp, was announced as winner of the Merchant Acquirer of the Year Award at the Cards & Payments Europe 2011 Conference and Awards Dinner.

22 Jun 2011

FGS expands service offering to European market through ISO 13485 medical certification

Flextronics Global Services (FGS), a business unit of Flextronics, today announced that it is expanding its service offering to the medical market in Europe through ISO 13485 medical certification at its Budapest facility.

22 Jun 2011

TESARO secures $101M in Series B financing

TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $101 million in a Series B financing to advance and expand the Company's cancer product portfolio.

21 Jun 2011

Indian biotechnology market to reach over $11 billion by 2017

The Indian biotechnology market is set to reach over $11 billion by 2017, according to a new report available on companiesandmarkets.com. The market will be driven by foreign investment, growing R&D and infrastructure investment, an emerging contract research market, drug discovery and growth in manufacturing outsourcing to India.

21 Jun 2011

BioLife becomes the leading supplier of pre-formulated cord blood stem cell freeze media products

BioLife Solutions, Inc., a leading developer and manufacturer of clinical grade biopreservation media products for cells and tissues, today announced that it has become the leading supplier of pre-formulated GMP cryopreservation media for umbilical cord blood stem cells, a key segment of the Company's strategic biobanking market.

21 Jun 2011

US E-Prescription Systems market to reach over $204.67 million by 2017

The US E-Prescription Systems market is forecast to reach $204.67 million, while the European market is forecast to reach $508.38 million by the year 2017, according to a new report on companiesandmarkets.com.

21 Jun 2011